Meet the Pioneer of Non-Surgical Thyroid Care

Dr. Kandil is a Professor of Surgery, the Elias Hanna Chair in Surgery and the Chief of General, Endocrine and Oncological Surgery Division at Tulane University Medical School, New Orleans, LA. He is also an executive member of the Tulane Cancer Executive Council and the director of the clinical Endocrine Surgery Fellowship at Tulane. He completed his training with a clinical fellowship in endocrine surgery at Johns Hopkins University School of Medicine in Baltimore, Maryland.

Dr. Emad Kandil serves as the chief of endocrine and oncological surgery at Tulane, and he is a passionate advocate of RFA for thyroid nodules. Dr. Kandil has trained in RFA outside of the United States, where the approach has been used for years in nodule treatment before FDA clearance here at home. He is the first specialist in the United States to complete more than 1000 cases Thyroid Ablation.

• Visiting professor, New York-Presbyterian Methodist Hospital, Innovations in Thyroid Surgery, January 16, 2024.
• Innovations in thyroid surgery, Ramses Multispecialty Robotic Microsurgery, Istanbul, Turkey, November 4, 2023.
• American College of Surgeons, Moderator and invited speaker, update of Radiofrequency Ablation for thyroid nodules, Boston, October 2023.
• Keynote speaker at the Canadian Society of Otolaryngology-Head and Neck Surgery Conference in Toronto, Canada, September 9, 2023.
• Invited speaker for the UNFURLS course on Radiofrequency Ablation (RFA) of thyroid nodules at the Canadian Society of Otolaryngology-Head and Neck Surgery Conference in Toronto, Canada, September 8, 2023.
• RFA for bilateral thyroid nodules, American Thyroid Association, September 2023.
• World Congress on Thyroid Cancer (WCTC), London, June 15-17, 2023. Invited speaker on updates on Radiofrequency Ablation for thyroid lesions and instructor for the RFA course prior to the meeting.
• Southern Society of Endocrinologists (SSE), New Orleans, LA, February 24, 2023. Invited speaker, Radiofrequency Ablation of thyroid cancers: Is it ready for prime time?
• Society of Surgical Oncology (SSO): Invited speaker, Radiofrequency Ablation for thyroid patients. Boston, March 23, 2023.
• Society of Surgical Oncology (SSO): Invited speaker and session moderator, Innovations in Endocrine Surgery. Dallas, March 11, 2022.
• Invited speaker and course director for the ultrasound course for surgeons, Shefaa El-Orman Oncology Hospital, 2nd Annual Conference, Luxor, Egypt, March 23, 2022.
• “Novel technologies in Endocrine Surgery,” Shefaa El-Orman Oncology Hospital, 2nd Annual Conference, Luxor, Egypt, March 23, 2022.
• Radiofrequency Ablation of thyroid nodules, Saudi Endocrine Society, presented via Zoom, March 28, 2022.
• Invited speaker and course instructor, AAES course on Radiofrequency Ablation, New York, New York, September 9, 2021.
• Invited speaker and panelist, Healthcare Disparity Panel, American Thyroid Association 90th Annual Meeting, virtual, October 3, 2021.
• Invited speaker, “Novel approaches for thyroid and parathyroid surgery,” National Cancer Institute (NCI), Cairo, Egypt, November 3, 2021.
• Presenter and moderator for Endocrine Surgery Session, Clinical Robotic Surgery Association (CRSA), virtual, July 14, 2021.
• Society of Surgical Oncology (SSO 2021) – Virtual Meeting: Session moderator – Endocrine, Head & Neck Virtual Forum, March 18, 2021.
• ASA Virtual 141st Annual Meeting, April 15-16, 2021. “Outcomes of Subtotal Parathyroidectomy Versus Total Parathyroidectomy.”
• Invited to serve as the surgical oncology expert panelist, SSO Endocrine Virtual Tumor Board: Session Moderator – Endocrine, Head & Neck Virtual Forum, February 22, 2021 – Thyroid cancer.